| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics, Inc. | SVP/Chief Medical Officer | Stock Option (Right to Buy) | 102,000 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics, Inc. | 11 Jul 2022 | 1 | $0 | 4 | SVP/Chief Medical Officer | 04 Aug 2022, 16:16 |
| QLGN | Qualigen Therapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | SVP/Chief Medical Officer | 10 Dec 2021, 05:15 |
| QLGN | Qualigen Therapeutics, Inc. | 17 May 2021 | 1 | $0 | 4 | SVP/Chief Medical Officer | 18 May 2021, 06:14 |
| QLGN | Qualigen Therapeutics, Inc. | 17 May 2021 | 0 | $0 | 3 | SVP/Chief Medical Officer | 17 May 2021, 16:23 |